Product

Bemnifosbuvir/Ruzasvir co-administered + Biktarvy

1 clinical trial

1 indication

Indication

Healthy Volunteer Study

Clinical trial

A Phase 1, Open-Label, Multiple Dose Study to Evaluate the Drug-Drug Interaction Potential Between Bemnifosbuvir/Ruzasvir and Bictegravir/Emtricitabine/Tenofovir Alafenamide (Biktarvy®) in Healthy Adult Subjects

Status: Not yet recruiting, Estimated PCD: 2024-05-30